Biotechnology Biohaven to Discuss First Quarter 2022 Financial Results and Recent Business Developments on May 11, 2022 May 9, 2022
Biotechnology Alkermes Announces Four Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting May 9, 2022
Biotechnology Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics May 9, 2022
Biotechnology Bragar Eagel & Squire, P.C. Is Investigating Dentsply, Cassava, and Axsome and Encourages Investors to Contact the Firm May 6, 2022
Search
Biotechnology
